CoQ10 vs Fish Oil for Aging Dog Heart Support: What the Evidence Actually Says

By Camille Akin, DVM

✓ Medically reviewed by Camille Akin, DVM — August 11, 2026 For general education — not a substitute for veterinary care.

Comparisons · August 11, 2026 · 6 min read

For an aging dog's heart, fish oil has real trial support; CoQ10's evidence is still catching up.

Does an aging heart actually need CoQ10, or is fish oil doing the real work?

I get asked this in exam rooms more than almost any other supplement question, usually right after a diagnosis of myxomatous mitral valve disease or early dilated cardiomyopathy. The owner has already read three forum threads and wants to know which capsule to buy first. My honest answer is that these two supplements aren’t interchangeable, and treating them as competitors misses the point — they’re supporting different parts of a very different problem.

A twelve-year-old Cavalier King Charles Spaniel named Winnie came in for her annual senior workup at 8.2 kilograms, down about half a kilogram from the year before. Her owner hadn’t noticed much beyond a soft cough after she settled down for the night and a reluctance to finish her usual after-dinner lap around the block. Winnie already had a grade III/VI murmur and mild left atrial enlargement on echo — textbook early MMVD for the breed. Her owner had read that CoQ10 could “strengthen the heart muscle” and wanted to start it that week, alongside or instead of the omega-3 capsule her regular vet had already recommended. Working through that differential with her is basically the whole article.

What the CoQ10 trials actually show

CoQ10 is a naturally occurring cofactor in mitochondrial energy production, concentrated in tissues with high energy demand — including cardiac muscle. The logic for supplementing it in heart disease is straightforward: MMVD hearts are working harder, so more CoQ10 should help them work more efficiently. The trial evidence in dogs is thinner than that logic suggests.

A randomized, double-blinded, controlled trial in the American Journal of Veterinary Research found that a daily dose of 200 mg of water-soluble CoQ10 reliably raised plasma CoQ10 concentration in dogs with MMVD — the supplement clearly gets absorbed. What it didn’t establish is whether that higher plasma level changes disease progression. A separate placebo-controlled study of 43 dogs across ACVIM stages B2 through C/D, tracked on PMC, used the same 100 mg twice-daily dose for three months and found no significant change in echocardiographic measurements, NT-proBNP, or troponin I — the markers cardiologists actually use to grade severity and response. Where CoQ10 did move the needle was on the white blood cell count: supplemented dogs in congestive heart failure showed a shift toward fewer neutrophils and more lymphocytes relative to placebo, a pattern consistent with less systemic inflammation. Owners in that study also reported subjective improvement, though the authors didn’t statistically analyze that part.

Cardiologists at Tufts Cummings School of Veterinary Medicine are similarly cautious, noting there are no definitive canine or feline studies establishing a clinical benefit, though some human dilated cardiomyopathy research is suggestive. That’s a fair summary of where I land, too: CoQ10 looks safe, it clearly raises blood levels, and it may modulate inflammation at the margins. It has not been shown to change how MMVD or DCM actually progresses in a dog.

What fish oil has actually shown in dogs with congestive heart failure

Fish oil’s case is built on a narrower but more concrete finding: cardiac cachexia. Dogs in congestive heart failure lose lean muscle mass through a cytokine-driven process, and that loss is associated with meaningfully shorter survival — this isn’t a cosmetic concern, it’s a prognostic one. Freeman’s landmark trial, published in the Journal of Veterinary Internal Medicine, found that EPA and DHA supplementation reduced interleukin-1 concentrations and improved markers of cachexia compared to placebo in dogs with heart failure. That’s a mechanism I can actually explain to an owner: omega-3s appear to blunt the inflammatory cytokines driving muscle wasting, and reduced cytokine activity has been linked to better survival odds in CHF dogs. Fish oil also carries independent support for reducing arrhythmia risk and easing the workload of a remodeling heart, which is why it shows up in most cardiac diets already. For more on how to vet a fish oil product for long-term use, see Is Fish Oil Safe for Dogs Long Term?, and if you’re weighing whole-food sources against a capsule, Wild Salmon vs. Fish Oil Supplements for a Senior Dog’s Brain covers that adjacent decision well.

One caveat worth saying plainly: fish oil doesn’t prevent heart disease in dogs the way it’s sometimes marketed to do in people, because dogs don’t typically develop the coronary artery disease that omega-3s are protecting against in that context. Its job here is supportive — managing inflammation and muscle preservation around a valve or muscle problem that already exists, not reversing the underlying lesion.

The dog who changed how I explain this trade-off

A ten-year-old Doberman named Gus came in about eight months after Winnie, already on furosemide and pimobendan for stage C DCM. His owner had noticed him skipping the second flight of stairs to the bedroom and losing the muscle definition along his topline — something she described as his back looking “sharper” than it used to. He’d dropped almost 10% of his body weight over four months despite eating well, which is the classic cachexia picture rather than simple weight loss. We added a fish oil product dosed to his weight specifically because his presentation matched what the Freeman data actually measured — muscle wasting and inflammatory markers, not a low CoQ10 level nobody had tested. Four months later his topline had filled back in and he was taking the stairs again. I can’t call that proof of anything beyond his own case, but it’s exactly the kind of dog the trial evidence was built to help.

Where I land, and the argument against it

If I had to recommend one supplement to start with in an aging dog with confirmed heart disease, it’s fish oil, dosed to the animal and ideally coordinated with the cardiac diet already prescribed. The strongest counterargument is that CoQ10 isn’t unsafe, it’s cheap relative to some fish oil products, and the inflammatory marker shift in the PMC data is a real signal, even if it’s not a survival endpoint. I take that seriously — CoQ10 isn’t a supplement I’d talk an owner out of if their dog is already stable and they want to add it on top of fish oil and their prescribed cardiac medications. What I won’t do is frame CoQ10 as a substitute for fish oil, or for the diet and medication plan a cardiologist has already built, when the evidence for CoQ10 changing disease course simply isn’t there yet. Both supplements are working to support normal cardiac and metabolic function alongside the treatment plan, not to treat the valve disease or cardiomyopathy itself — that distinction matters more than which bottle you buy first.

If you’re also weighing supplement formats for an older dog on multiple medications, Freeze-Dried vs. Powder Supplements for Dogs is a useful next read for figuring out what’s actually easiest to dose consistently.

Your checklist before you add either one

Confirm the diagnosis and stage first — a cardiologist’s echo report tells you far more than a supplement label does. Ask whether your dog is showing muscle loss, reduced appetite, or a dropping body condition score, since that’s the pattern fish oil has actual trial support for addressing. Get the EPA/DHA dose from your vet rather than eyeballing a human bottle, since concentration varies widely between products. If you’re adding CoQ10 on top of that plan, treat it as a low-risk addition rather than a replacement for anything already prescribed. And recheck body weight and muscle condition score at every visit — that’s the marker most likely to tell you whether either supplement is doing its job.

What would change my mind on CoQ10 is a trial that actually links it to slower disease progression rather than a lab value. Until that exists, I’m going to keep reaching for fish oil first and letting CoQ10 be the optional add-on it currently is.